SCHEMBL13699107

SCHEMBL13699107

CCCc1cc(C(N)=S)ccc1OCCCOc1ccc2c(ccn2CC)c1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.60
PPARA Q07869 15/20 0.60
PPARD Q03181 11/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4223705 0.90 PPARG (0.75) PPARGPPARAPPARD
SCHEMBL12568368 0.88 PPARG (0.63) PPARGPPARAPPARD
SCHEMBL2004565 0.83 PPARG (0.55) PPARGPPARAPPARD
SCHEMBL18644984 0.77 PPARG (0.87) PPARGPPARAPPARD
SCHEMBL23658023 0.75 PLAU (0.51)
SCHEMBL5008655 0.75 PPARG (1.00) PPARGPPARAPPARD
SCHEMBL4228991 0.74 PPARG (0.69) PPARGPPARAPPARD
SCHEMBL12621106 0.72 PPARG (0.51) PPARGPPARAPPARD
SCHEMBL13699062 0.72 PPARG (0.57) PPARGPPARAPPARD
SCHEMBL12621671 0.72 PPARA (0.59) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592361-B2 (5-{3-[4-(4,5,6,7-tetrahydro-benzooxazol-2-yl)-phenoxy]-propoxy}-indol-1-yl)-acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic disease BAYER PHARMACEUTICALS CORPORATION (US) 2009-09-22 US disclosed